A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
Trial details
- Registry ID
- NCT07615010
- Drugs studied
- Standard of Care (SOC), agenT-797
TrialRedline tracks 1 clinical trial sponsored by MiNK Therapeutics: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory FailureNCT07615010 | Standard of Care (SOC), agenT-797 | Recruiting | 2027-06Estimated |
Names as written in the registry records.